STEVENS CAPITAL MANAGEMENT LP - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2015$177,000
-27.8%
59,957
-22.6%
0.01%
-36.4%
Q3 2015$245,000
+0.8%
77,513
+88.9%
0.01%
+22.2%
Q2 2015$243,00041,0380.01%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,134,578$10,654,0007.22%
Consonance Capital Management LP 3,427,789$32,187,0004.15%
ACUTA CAPITAL PARTNERS, LLC 604,075$5,672,0003.83%
KOPP INVESTMENT ADVISORS LLC 758,233$7,119,0003.42%
Aisling Capital LLC 2,010,000$18,874,0002.86%
Broadfin Capital, LLC 6,100,000$57,280,0002.49%
THOMPSON DAVIS & CO., INC. 154,760$1,453,0001.68%
RUDMAN ERROL M 300,000$2,817,0001.14%
WALL STREET ASSOCIATES 1,259,500$11,827,0001.13%
Timpani Capital Management LLC 291,377$2,736,0001.08%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders